Quarterly report pursuant to Section 13 or 15(d)

Note 24 - Segment Information: Schedule of Segment Information (Details)

v3.19.1
Note 24 - Segment Information: Schedule of Segment Information (Details) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating income (loss) $ (856,244) $ (220,071)
Interest income 42,580 39,067
Interest expense 4,523 4,128
Depreciation and amortization 5,428 2,549
Cannabis and Medical Marijuana Segment    
Net revenue 120,089 160,528
Operating income (loss) (606,697) 76,765
Interest income 20,679 23,421
Interest expense 0 0
Property additions 0 0
Depreciation and amortization 0 0
Facility Operations Related    
Net revenue 955,906 855,671
Operating income (loss) 171,179 26,487
Interest income 3 0
Interest expense 5,657 5,262
Property additions 156,891 0
Depreciation and amortization 8,020 2,592
Corporate and Eliminations    
Net revenue 0 0
Operating income (loss) (266,726) (323,323)
Interest income 21,898 15,646
Interest expense (1,134) (1,134)
Property additions 0 2,399
Depreciation and amortization 2,932 1,708
Consolidated    
Net revenue 1,075,995 1,016,199
Operating income (loss) (856,244) (220,071)
Interest income 42,580 39,067
Interest expense 4,523 4,128
Property additions 156,891 2,399
Depreciation and amortization $ 10,952 $ 4,300